Xtl Biopharmaceuticals (XTLB) Non Operating Investment Income (2012 - 2024)
Xtl Biopharmaceuticals (XTLB) posted Non Operating Investment Income of $5,000 for the year ended Dec 31, 2025, down 97.0% from $167,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Non Operating Investment Income (2012 - 2024) Analysis & Trends
Since the year ended Dec 31, 2012, Xtl Biopharmaceuticals has reported Non Operating Investment Income for 6 years.
- Annual Non Operating Investment Income has run from a low of -$1.53 million in the year ended Dec 31, 2022 to a high of $167,000 in the year ended Dec 31, 2024 over five years.
- Business Quant data shows XTLB's Non Operating Investment Income at $167,000 in the year ended Dec 31, 2024, -$1.02 million in the year ended Dec 31, 2023 and -$1.53 million in the year ended Dec 31, 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.03 Bn | 2.03 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 485,000.00 |
| Jun 30, 2023 | -364,000.00 |
| Mar 31, 2023 | -919,000.00 |
| Jun 30, 2022 | -285,000.00 |
| Mar 31, 2022 | 506,000.00 |
| Sep 30, 2018 | 1.03 Mn |
| Jun 30, 2018 | 34,000.00 |
| Mar 31, 2018 | 875,000.00 |
| Sep 30, 2017 | 1.53 Mn |
| Jun 30, 2017 | -1.42 Mn |
| Mar 31, 2017 | -980,000.00 |
| Jun 30, 2016 | 84,000.00 |
| Jun 30, 2014 | -259,000.00 |
| Sep 30, 2013 | 264,000.00 |
| Mar 31, 2013 | -190,000.00 |
| Dec 31, 2012 | -1.26 Mn |
| Sep 30, 2012 | -150,000.00 |
| Mar 31, 2012 | 212,000.00 |
API Access
Xtl Biopharmaceuticals Non Operating Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();